RATIONALE: Transcriptional coactivator with PDZ-binding motif (TAZ) is assumed to act as a coactivator of several transcription factors including smad2/3. In the lung, surfactant protein C (Sftpc) is known to be a downstream target of thyroid transcription factor-1 (TTF-1)-TAZ transcriptional coactivation. OBJECTIVES: The lung phenotype of Taz-deficient mice was explored. METHODS: Taz-deficient mice were analyzed pathologically and physiologically. Next, we performed microarray analysis to determine the genes closely related to abnormal lung development. Finally, Taz-heterozygous mice were injected with bleomycin. MEASUREMENTS AND MAIN RESULTS: Taz-deficient homozygotes showed abnormal alveolarization during lung development, which caused in adult mice airspace enlargement mimicking emphysema. There was no significant difference in the expression of Sftpc between wild-type and Taz-deficient lungs. Instead, microarray analysis identified some candidate downstream genes related to the pathogenesis, including the connective tissue growth factor (Ctgf) gene, which is required for normal lung development. In vitro studies showed that TAZ up-regulated Ctgf expression not only by reinforcing transforming growth factor-beta/smad signals, but also by interfering in the more proximal Ctgf promoter region (from bp -123 to -76), defined as the TAZ response element. Furthermore, Taz-heterozygous mice were resistant to bleomycin-induced lung fibrosis. CONCLUSIONS: The results indicate the importance of TAZ in lung alveolarization and its involvement in the pathogenesis of lung fibrosis.
RATIONALE: Transcriptional coactivator with PDZ-binding motif (TAZ) is assumed to act as a coactivator of several transcription factors including smad2/3. In the lung, surfactant protein C (Sftpc) is known to be a downstream target of thyroid transcription factor-1 (TTF-1)-TAZ transcriptional coactivation. OBJECTIVES: The lung phenotype of Taz-deficient mice was explored. METHODS: Taz-deficient mice were analyzed pathologically and physiologically. Next, we performed microarray analysis to determine the genes closely related to abnormal lung development. Finally, Taz-heterozygous mice were injected with bleomycin. MEASUREMENTS AND MAIN RESULTS: Taz-deficient homozygotes showed abnormal alveolarization during lung development, which caused in adult mice airspace enlargement mimicking emphysema. There was no significant difference in the expression of Sftpc between wild-type and Taz-deficient lungs. Instead, microarray analysis identified some candidate downstream genes related to the pathogenesis, including the connective tissue growth factor (Ctgf) gene, which is required for normal lung development. In vitro studies showed that TAZ up-regulated Ctgf expression not only by reinforcing transforming growth factor-beta/smad signals, but also by interfering in the more proximal Ctgf promoter region (from bp -123 to -76), defined as the TAZ response element. Furthermore, Taz-heterozygous mice were resistant to bleomycin-induced lung fibrosis. CONCLUSIONS: The results indicate the importance of TAZ in lung alveolarization and its involvement in the pathogenesis of lung fibrosis.
Authors: Fei Liu; David Lagares; Kyoung Moo Choi; Lauren Stopfer; Aleksandar Marinković; Vladimir Vrbanac; Clemens K Probst; Samantha E Hiemer; Thomas H Sisson; Jeffrey C Horowitz; Ivan O Rosas; Laura E Fredenburgh; Carol Feghali-Bostwick; Xaralabos Varelas; Andrew M Tager; Daniel J Tschumperlin Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-12-12 Impact factor: 5.464
Authors: Tianhe Sun; Zhiyu Huang; Hua Zhang; Clara Posner; Guiquan Jia; Thirumalai R Ramalingam; Min Xu; Hans Brightbill; Jackson G Egen; Anwesha Dey; Joseph R Arron Journal: JCI Insight Date: 2019-06-18
Authors: Xiaobo Wang; Ze Zheng; Jorge Matias Caviglia; Kathleen E Corey; Tina M Herfel; Bishuang Cai; Ricard Masia; Raymond T Chung; Jay H Lefkowitch; Robert F Schwabe; Ira Tabas Journal: Cell Metab Date: 2016-10-27 Impact factor: 27.287
Authors: K Otsubo; H Goto; M Nishio; K Kawamura; S Yanagi; W Nishie; T Sasaki; T Maehama; H Nishina; K Mimori; T Nakano; H Shimizu; T W Mak; K Nakao; Y Nakanishi; A Suzuki Journal: Oncogene Date: 2017-03-27 Impact factor: 9.867
Authors: Alexander W Lange; Anusha Sridharan; Yan Xu; Barry R Stripp; Anne-Karina Perl; Jeffrey A Whitsett Journal: J Mol Cell Biol Date: 2014-12-05 Impact factor: 6.216